JavaScript is NOT enabled !

Please enable JavaScript.

Article

PubMed

This record comes from PubMed

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Dimopoulos, M A
Author Dimopoulos, M A Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Moreau, P
Author Moreau, P Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
Terpos, E
Author Terpos, E Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Mateos, M V
Author Mateos, M V University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain
Zweegman, S
Author Zweegman, S Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
Cook, G
Author Cook, G Leeds Cancer Centre and University of Leeds, Leeds, UK
Delforge, M
Author Delforge, M Department of Hematology, University Hospital Leuven, Leuven, Belgium
Hájek, R
Author Hájek, R Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic
Schjesvold, F
Author Schjesvold, F Oslo Myeloma Center, Oslo University Hospital, Oslo; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
Cavo, M
Author Cavo, M Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
Goldschmidt, H
Author Goldschmidt, H University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany
Facon, T
Author Facon, T Hôpital Claude Huriez, Lille University Hospital, Lille, France
Einsele, H
Author Einsele, H Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany
Boccadoro, M
Author Boccadoro, M Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy
San-Miguel, J
Author San-Miguel, J Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain
Sonneveld, P
Author Sonneveld, P Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands
Mey, U
Author Mey, U Department of Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland
EHA Guidelines Committee. Electronic address: guidelines@ehaweb.org
Author EHA Guidelines Committee. Electronic address: guidelines@ehaweb.org
ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Author ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Annals of oncology. 2021 Mar ; 32 (3) : 309-322. [epub] 20210203

Ann Oncol
ISSN 1569-8041 | 0923-7534
Source

Language English Country England, Great Britain Media print-electronic

Document type Practice Guideline, Journal Article

Persistent link https://www.medvik.cz/link/pmid33549387

PubMed 33549387
DOI 10.1016/j.annonc.2020.11.014
PII: S0923-7534(20)43169-2
Knihovny.cz E-resources

Keywords
clinical practice guidelines, diagnosis, follow-up, multiple myeloma, prognosis, treatment,
MeSH
Humans MeSH
Multiple Myeloma * diagnosis epidemiology therapy MeSH
Follow-Up Studies MeSH
Societies, Medical MeSH
Check Tag
Humans MeSH
Publication type
Journal Article MeSH
Practice Guideline MeSH

Clinica Universidad de Navarra CIMA IDISNA CIBERONC Pamplona Spain

Department of Clinical Therapeutics School of Medicine National and Kapodistrian University of Athens Athens Greece

Department of Hematology Amsterdam UMC Vrije Universiteit Amsterdam Cancer Center Amsterdam Amsterdam Netherlands

Department of Hematology University Hospital Hôtel Dieu Nantes France

Department of Hematology University Hospital Leuven Leuven Belgium

Department of Internal Medicine 2 University Hospital Wurzburg Wurzburg Germany

Department of Oncology and Hematology Kantonsspital Graubünden Chur Switzerland

Division of Hematology University of Torino AOU Città della Salute e della Scienza di Torino Torino Italy

Erasmus Medical Center Cancer Institute Rotterdam Netherlands

Faculty of Medicine University Hospital Ostrava Ostrava Czech Republic

Hôpital Claude Huriez Lille University Hospital Lille France

Leeds Cancer Centre and University of Leeds Leeds UK

Oslo Myeloma Center Oslo University Hospital Oslo; KG Jebsen Center for B Cell Malignancies University of Oslo Oslo Norway

Seràgnoli Institute of Hematology Bologna University School of Medicine Bologna Italy

University Hospital Heidelberg Internal Medicine 5 and National Center for Tumor Diseases Heidelberg Germany

University Hospital of Salamanca IBSAL Cancer Research Center Salamanca Spain

Erratum In

Ann Oncol. 2022 Jan;33(1):117. doi: 10.1016/j.annonc.2021.10.001. PubMed

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma

Nature reviews. Clinical oncology. 2025 Jul 07 ; () : . [epub] 20250707

Nat Rev Clin Oncol
ISSN 1759-4782 | 1759-4774
Source

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group

BMC cancer. 2025 Apr 09 ; 25 (1) : 651. [epub] 20250409

BMC Cancer
ISSN 1471-2407
Source

Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Bone marrow transplantation. 2025 Feb ; 60 (2) : 211-219. [epub] 20241112

Bone Marrow Transplant
ISSN 1476-5365 | 0268-3369
Source

Detection of early relapse in multiple myeloma patients

Cell division. 2025 Jan 29 ; 20 (1) : 4. [epub] 20250129

Cell Div
ISSN 1747-1028
Source

Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow Cytometry

European journal of haematology. 2025 Jan ; 114 (1) : 155-163. [epub] 20241010

Eur J Haematol
ISSN 1600-0609 | 0902-4441
Source

ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study

Haematologica. 2024 Mar 01 ; 109 (3) : 867-876. [epub] 20240301

ISSN 1592-8721 | 0390-6078
Source

An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT

Bone marrow transplantation. 2023 Aug ; 58 (8) : 916-923. [epub] 20230509

Bone Marrow Transplant
ISSN 1476-5365 | 0268-3369
Source

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

ESMO open. 2022 Apr ; 7 (2) : 100403. [epub] 20220128

ESMO Open
ISSN 2059-7029
Source

2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

Haematologica. 2021 Nov 01 ; 106 (11) : 2799-2812. [epub] 20211101

ISSN 1592-8721 | 0390-6078
Source

Borrow
RIS

Find record

In BMC

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Find record

Citation metrics

Archiving options